Cannabidiol (CBD) and Tetrahydrocannabinol (THC) are two of the main active substances in cannabis: both are cannabinoids. Many cannabis species are known to contain a high level of THC and low CBD. However the medical community is now building up on CBD. We list here the main differences between these two substances, which makes CBD a trendy legal non-psychotic substance.
- Anti-Psychotic: Unlike THC psychoactive drug (or psychotomimetic) effects when use highly concentrated, CBD has anti-psychotic effects. It protects from the psychotic/narcotic effects of THC and is a legal substance.
- Focus: THC is the psychoactive substance in cannabis where CBD is has anti-psychotic effects. CBD can help to concentrate and focus, and even to be more resolute.
- Antioxidant: Just like green tea, CBD has antioxidant effect, which reduces or prevents oxidation of other parts of our body, and especially the absorption of free radicals.
- Anti-anxiety: THC is known to make some people anxious or paranoid. But CBD is known to have the opposite effect. In fact, studies have shown that CBD acts to counteract the effects of anxiety caused by THC. Other studies also showed that CBD can reduce anxiety when administered alone.
- Natural Sleep: One of the most common use of cannabis is to help falling asleep, in which TCH participate actively. Although CBD is not acting as a sleeping pill, it is its anti-anxiety effect which can help finding a state of natural sleep. Opposite effects of THC and CBD explains why certain varieties of cannabis are giving a more sleepy effect and others make a person more active.
- Legal status: While most countries prohibit THC, CBD is not classified as being a narcotic substance but remains astonishing…
On this basis, it is interesting to use products highly concentrated in CBD. For that purpose, producers are growing for many years already hemp species with very low THC.
 Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO (August 2007). “Cannabidiol–recent advances”. Chem. Biodivers. (Review) 4 (8): 1678–92. doi:10.1002/cbdv.200790147. PMID 17712814